
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
2
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
3
Ocular Therapeutix randomizes first patient in HELIOS-3
4
AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care
5











































































.png)


